In a randomized, controlled study of 24 patients undergoing myocardial revascularization, we found that enoximone 0.5 mg kg in the control group until core temperature had increased to 37 °C (P:0.001); only then did peripheral temperatures begin to increase in the control group. Enoximone did not merely redistribute heat from the core to the periphery. The capacity to transfer heat by the circulation rather than the ability to generate heat in the core appeared to limit body warming in the ICU after hypothermic cardiopulmonary bypass. (Br. J. Anaesth. 1995; 75: 43-46) 
Hypothermia is used during cardiopulmonary bypass (CPB) to reduce metabolic rate and oxygen and substrate requirements [1] . Hypothermia is associated with shivering [2] , although not all postanaesthetic shivering is related to hypothermia and this shivering may differ from thermoregulatory shivering [3] . Shivering may imbalance oxygen supply and delivery to the tissues [4] [5] [6] . Hypothermia may prolong drug action [7] and impair coagulation [8, 9] . It is also commonly thought that patients should be normothermic before tracheal extubation [10, 11] . There are various measures to correct hypothermia after surgery, including cotton blankets, the "space blanket" warm water blankets, electric heating blankets and radiant heating lamps. Most have been found to reduce heat loss [12, 13] or alter its distribution in the body loss rather than warm the patient actively.
Vasodilators in common use after coronary artery surgery include sodium nitroprusside and glyceryl trinitrate. Sodium nitroprusside reduces the increase in mean arterial pressure and systemic vascular resistance after coronary artery surgery and increases cardiac index, but these changes do not influence the pattern of rewarming [14] . Sodium nitroprusside increases plasma and red cell cyanide concentrations with the risk of metabolic acidosis [15] . Glyceryl trinitrate also reduces systemic vascular resistance, pulmonary artery wedge pressure and left ventricular stroke work index, but cardiac index and stroke index are unchanged [16] . It reduces preload in the failing heart [17] , but its use may necessitate further i.v. fluid therapy for patients who have already received 1-2 litre of crystalloid pump prime.
During the active phase of warming after hypothermic cardiopulmonary bypass (CPB), patients appeared to warm rapidly while infusions of enoximone were in progress. An open pilot study of six patients indicated that nasopharyngeal temperatures in control patients warmed at 0.5 °C min
Ϫ1
, whereas patients in whom enoximone was infused warmed at 1.2 °C min Ϫ1 . A randomized study was then designed to investigate enoximone and warming after hypothermic CPB.
Patients and methods
After obtaining local Ethics Committee approval and written informed consent, we studied 24 patients admitted for elective myocardial revascularization. and pancuronium 0.05 mg kg Ϫ1 i.v. at rewarming. A list of either "enoximone" or "control" was generated using the pseudo-random function of a personal computer. Patients were allocated from that list to a group in sequence as recruited. when 28-30 °C. Cooling and rewarming were standardized. In all patients, a Thermomat T1000 electric mattress (JMW Medical Systems, Edinburgh, UK) was separated from the patient's back by a canvas stretcher cover. When cooling, the mattress was set at 29 °C and the water temperature of the heater-cooler water circulator (Gambro, Sidcup, UK) reduced to 20 °C, until core temperature reached the desired value. Water temperature was then changed to the same value as core temperature. When warming, the mattress was dialled to 39 °C and the water temperature of the heater-cooler water circulator increased to 42 °C until core temperature reached 37.5 °C. The water temperature was then reduced to 39 °C. When rewarming was requested, patients in the enoximone group received only enoximone 0.5 mg kg Ϫ1 i.v. over 10 min followed by an infusion of enoximone 5 mg kg Ϫ1 min Ϫ1 i.v. until core temperature was 37 °C in the ICU.
After induction of anaesthesia, temperature was measured by a thermocouple (Mallinckrodt, Northampton, UK) sited against the tympanic membrane (core) and on the dorsum of the foot (peripheral). Temperatures were displayed continuously by a Mon-a-Therm 700 unit (Mallinckrodt, Northampton, UK) and logged to computer disc every 20 s. Temperature monitoring was interrupted during transfer from the operating theatre to the ICU, but reconnected there until a core temperature of 37 °C was attained.
The heat removed from and replaced to patients was recorded using an energy balance meter [18] . Temperatures in wells in the arterial and venous limbs of the bypass circuit were recorded by YSI 400 series thermistors. The number of complete revolutions of the pump base were recorded via an infrared sensor mounted on the perspex cover above the pump. One complete cycle of the pump propelled 27 ml of blood. Using values of density and specific heat capacity (shc) of blood of 1.0 kg litre Ϫ1 [19, 20 ] and 3.77 J kg Ϫ1 °C Ϫ1 [20] , energy transfer between pump and patient was calculated by: Values of energy transfer, time and core temperature were logged to computer every minute. Core and peripheral temperatures were recorded in the ICU following transfer from theatre. On admission to the ICU, patients were covered with a hospital sheet, a plasticized aluminium foil space blanket (Harrison Insulating Systems, Haslingden, UK) and finally a hospital cellular blanket. There was no heated mattress under patients in the ICU.
Temperature data were plotted against time. Least squares regression analysis was used to determine the rate of change of temperature. Statistical analysis was performed using analysis of variance and the Kruskal-Wallis test where appropriate. Statistical significance was accepted when P Ͻ 0.05.
Results
There were no differences between the groups in sex distribution, age, weight, height, body surface area or body mass index (table 1) .
The conduct of CPB did not differ between the groups. Time cold was from initiation of CPB until the decision to rewarm. Time warming was from the decision to rewarm until the end of CPB. The sum of time cold and time warming was equal to the duration of CPB. There were no differences between the groups with respect to bypass times, core temperature when cold, heat removed from and returned to the body from the bypass circuit or the rate of increase core temperature during warming (table 2) .
Temperature data were plotted against time. Distinct from phases of active cooling and warming during CPB, plots of temperature against time appeared to increase or decrease linearly. There were no differences between the groups in the highest (peak) core and foot temperatures recorded after weaning from CPB, the subsequent lowest (trough) temperatures recorded before body temperature began to increase again in the ICU, the rate of warming of the core in the ICU or the time taken from admission to ICU until core temperature reached 37 °C (table 3) . Mean skin surface temperatures on the foot increased immediately from admission to ICU by 0.33 (SD 0.5) °C h Ϫ1 in the enoximone group, but decreased by 0.43 (0.4) °C h Ϫ1 in the control group until core temperature had increased to 37 °C (P Ͻ 0.001). Only then did peripheral temperatures begin to increase in the control group (figs 1, 2).
Discussion
An i.v. infusion of enoximone prevented further cooling of the periphery in the ICU after hypothermic CPB. Temperatures decreased in all patients from 37 to 38 °C (core) and from 31 to 32 °C (periphery) after weaning from CPB until patients were transferred to a bed and covered by bedclothes. Subsequent lowest temperatures recorded were 35-36 °C (core) and 28-29 °C (periphery). Both core and peripheral temperatures in the enoximone group increased progressively, immediately after admission to the ICU. In the control group, core temperatures increased steadily at the same rate as those in the enoximone group, but peripheral temperatures continued to decrease until core temperature had reached 37 °C; only then did peripheral temperatures begin to increase in the control group. The cost of enoximone used was comparable with that of a disposable paper blanket used in convective warming [11] .
Enoximone did not merely redistribute heat from the core to the periphery. There was a tendency for the mean rates of increase of core temperature in the enoximone group to be higher, and a core temperature of 37 °C to be reached sooner in the enoximone group than in the control group, although the differences were not significant.
Enoximone increases cardiac index and decreases systemic vascular resistance in patients after cardiac surgery [21] . The enhanced capacity of the circulation to transfer heat from the core to the periphery may explain the accelerated peripheral warming in the enoximone group. The ability to generate heat in the core did not appear to limit body warming in the ICU.
The pilot study suggested more rapid warming with enoximone during the active phase of warming during CPB, while patients lay on a Ripple Heat circulating water mattress (Hawksley, Lancing, UK) with a stated output of 750 W. When the randomized study was undertaken, all patients lay on a Thermomat T1000 (JMW Medical Systems, Edinburgh, UK) electric blanket which could deliver a maximum of 125 W; 1000 kJ delivered by the bypass circuit over 40 min is equivalent to 400 W. A substantial difference in the heat supplied to the back of the patient during active warming during CPB may have contributed to the marked increase in the rate of warming in the pilot study in patients in whom enoximone had reduced vascular resistance [15] and altered the distribution of the blood circulated by the bypass pump. In the controlled study, active warming lasted mean 34 (SD 11) min in the enoximone group and 40 (16) min in the control group. The 125-W electric mattress was not associated with a difference in warming pattern between the groups while patients lay on it. Figure 2 Core (---) and peripheral (---) temperatures for a patient in the enoximone group. Rapid changes in temperature occurred during active warming and cooling during cardiopulmonary bypass. Figure 1 Core (---) and peripheral (---) temperatures for a patient in the control group. Rapid changes in temperature occurred during active warming and cooling during cardiopulmonary bypass.
